NCT06728501

Brief Summary

The aim of the study is to investigate whether structured diabetes mellitus education leads to improved blood glucose control in Turkmenistan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

December 6, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

December 6, 2024

Last Update Submit

December 6, 2024

Conditions

Diabetes Mellitus, Type 2

Outcome Measures

Primary Outcomes (1)

  • Change in HbA1c

    6 months

Study Arms (2)

Diabetes education

ACTIVE COMPARATOR

Patients receive diabetes education

Behavioral: Diabetes education

Control

NO INTERVENTION

Patients receive no diabetes education

Interventions

Diabetes educationBEHAVIORAL

Patients receive 5 hours of diabetes education

Diabetes education

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • type 2 diabetes

You may not qualify if:

  • type 1 diabetes
  • diabetes duration \< 1 year
  • severe comorbidities
  • abuse of alcohol or drugs
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

International Center of Surgery and Endocrinology, Ashgabat, Turkmenistan

Ashgabat, Turkmenistan

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof of Endocrinology and Metabolism

Study Record Dates

First Submitted

December 6, 2024

First Posted

December 11, 2024

Study Start

February 1, 2022

Primary Completion

July 31, 2022

Study Completion

July 31, 2022

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)